Home Podcasts Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals
Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Cleveland Clinic Heart & Vascular Institute 357 Episodes Oct 15, 2026

A Cleveland Clinic podcast exploring heart, vascular and thoracic topics of interest to healthcare providers: medical and surgical treatments, diagnostic testing, medical conditions, and research, technology and practice issues.

Episodes

Talking Tall Rounds® Cardiac Sarcoidosis: Systematic Team Approach to Diagnosis & Management
Talking Tall Rounds® Cardiac Sarcoidosis: Systematic Team Approach to Diagnosis & Management Oct 15, 2026 995 In this excerpt from Tall Rounds®, Cleveland Clinic experts discuss imaging modalities that aid the diagnosis of cardiac sarcoidosis. The conversation explores diagnostic challenges, risk stratification, interpretation pitfalls and the role of serial imaging in assessing treatment response and guiding clinical decision-making.View other Tall Rounds programs. https://2207941.mediaspace.kaltura.com/
Evolving Strategies in Aortic Arch Repair
Evolving Strategies in Aortic Arch Repair Oct 8, 2026 1429 Eric Roselli, MD, and Patrick Vargo, MD, discuss how advances in open, hybrid and endovascular techniques are changing the treatment of aortic arch disease. They explore evolving approaches to aneurysms and dissections, innovations in brain protection and the role of specialized aortic centers in improving patient outcomes.Looking to refer a patient? Please reach out to our Physician Referral team
Management of Complex Aortic Valve Endocarditis
Management of Complex Aortic Valve Endocarditis Oct 1, 2026 814 Milind Desai, MD, and Per Wierup, MD, discuss the evaluation and management of high-risk aortic valve endocarditis, including indications for urgent intervention and timing of surgery. They also review operative approaches to patients with heart failure, uncontrolled infection and embolic risk, highlighting the role of multidisciplinary expertise in complex endocarditis careLooking to refer a pati
Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk
Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk Sep 24, 2026 548 Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phospholipids and lipoprotein(a). They discuss the potential mechanisms linking lipoprotein(a) to cardiovascular risk and how ongoing phase 3 research may shape future management of patients with elevated lipoprotein(a).Looking to refer a patient? Please reach out
Talking Tall Rounds®: Updates on Less Invasive Cardiac Surgery
Talking Tall Rounds®: Updates on Less Invasive Cardiac Surgery Sep 17, 2026 804 In this excerpt from Tall Rounds®, Gianluca Torregrossa, MD, discusses minimally invasive and totally endoscopic coronary artery bypass grafting (TECAB), highlighting procedural advances that enable multi-vessel revascularization through less invasive approaches. Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.View the f
CTX310 and the Future of Gene Editing for Lipid Disorders
CTX310 and the Future of Gene Editing for Lipid Disorders Sep 10, 2026 385 Steven Nissen, MD, and Luke Laffin, MD, discuss one-year follow-up data for CTX310, a CRISPR-Cas9 gene-editing therapy targeting ANGPTL3 to treat lipid disorders. They review the sustained reductions in LDL cholesterol and triglycerides, and the potential role of one-time gene-editing therapies in cardiovascular prevention and lipid management.Read the article. https://consultqd.clevelandclinic.or
Evaluating Kylo-11 for Long-Acting Lipoprotein(a) Suppression
Evaluating Kylo-11 for Long-Acting Lipoprotein(a) Suppression Sep 3, 2026 463 Steven Nissen, MD, and Ashish Sarraju, MD, discuss early clinical data on Kylo-11, a novel therapy that produced substantial reductions in lipoprotein(a) for up to one year after a single injection. Lowering lipoprotein(a), a genetically determined cardiovascular risk factor linked to atherosclerotic disease and aortic stenosis, remains an important focus for preventive cardiology. Learn about the
Robotic Approaches to Mitral and Aortic Valve Surgery
Robotic Approaches to Mitral and Aortic Valve Surgery Aug 27, 2026 589 Marc Gillinov, MD, and Per Wierup, MD, discuss the evolution of robotic valve surgery, including advanced mitral valve repair techniques, patient selection and expanding applications for aortic valve and coronary procedures. They examine how enhanced visualization, instrument dexterity and a mature robotic program support excellent safety, durability and clinical outcomes.Looking to refer a patien
Infective Endocarditis Diagnosis and Management
Infective Endocarditis Diagnosis and Management Aug 20, 2026 752 Bo Xu, MD, and Shinya Unai, MD, discuss approaches to diagnosing and treating infective endocarditis, including indications for surgical intervention. The conversation highlights the role of multimodality imaging , individualized surgical planning and multidisciplinary care strategies to improve patient outcomes.Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri
Expanding Coronary Revascularization With TECAB
Expanding Coronary Revascularization With TECAB Aug 13, 2026 1371 Donna Kimmaliardjuk, MD, and Gianluca Torregrossa, MD, discuss the expanding role of robotic coronary artery bypass grafting, including total endoscopic coronary artery bypass (TECAB). They explore how a tailored surgical approach can improve long-term patient outcomes.Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.
Stenting, Surgery and Hybrid Strategies for Coronary Disease
Stenting, Surgery and Hybrid Strategies for Coronary Disease Aug 6, 2026 723 Faisal Bakaeen, MD, and Grant Reed, MD, discuss recent advances in the treatment of coronary artery disease, including drug-coated balloons, intravascular imaging, calcium modification and evolving PCI strategies. They also examine innovations in coronary artery bypass grafting, multi-arterial revascularization, minimally invasive and robotic techniques and the growing role of heart team collabora
Individualizing Aspirin Therapy in Preventive Cardiology
Individualizing Aspirin Therapy in Preventive Cardiology Jul 30, 2026 739 Luke J. Laffin, MD, and Vikas Sunder, MD, discuss the evolving role of aspirin in primary prevention, emphasizing individualized assessment of each patient's cardiovascular and bleeding risk. They explore how coronary artery calcium scores, lipoprotein(a) levels and comorbid conditions factor into aspirin recommendations in contemporary preventive cardiology practice.Looking to refer a patien

Recommended